Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 3,681 shares at $0.98 ($4K) on 2022-11-02, disclosed to the SEC on 2022-11-03.
Open-market sale of $4k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 1,675 | $2K | 45.5% |
| 2 | $0.98 | 2,006 | $2K | 54.5% |
| Total | $0.98 avg | 3,681 | $4K | 100% |
| Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-03-03 | $20K | — | Filing → |